Company · Reading
Medicines Evaluation Unit Limited
Other research and experimental development on natural sciences and engineering
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Medicines Evaluation Unit Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 14
- Elizabeth Pamela Batty 2024-2025 View profile
- Professor Jorgen Vestbo 2018-2025 View profile
- Andrew Edward Mcnish 2015-2025 View profile
- Professor Ashley Arthur Woodcock 2015-2025 View profile
- Dr Robert Mclay Niven 2005-2024 View profile
- Professor Sukh Dave Singh 2004-2025 View profile
- Dr Stephen Langley 2003-2005 View profile
- David Rogers 2001-2025 View profile
- Anthony Kevin Webb 2000-2018 View profile
- Dr Philip Vernon Barber 2000-2025 View profile
- Kevin George Bilyard 2000-2001 View profile
- Professor Charles Anthony Cary Pickering 1999-2018 View profile
- Benjamin James Fielding 2000-2001 View profile
- Dr Andrew James Williams 1999-2001 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- What it does
- Other research and experimental development on natural sciences and engineering
- Incorporated
- 28/05/1999
- Registered office
- Reading
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Iqvia LTD.
75-100% shares, 75-100% voting, appoints directors · notified 2025-06-13
Group
- Medicines Evaluation Unit Limited
is controlled by Iqvia LTD.
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2025-06-13 · source: Companies House PSC register - Iqvia LTD.
is controlled by Iqvia RDS Holdings
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register - Iqvia RDS Holdings
is controlled by Iqvia RDS UK Holdings LTD.
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by Iqvia RDS UK Holdings LTD..
51 other companies in this group
- Drugdev Limited
- Clintec International LTD.
- Pharmaspectra Topco LTD
- Pharmaspectra Midco 1 LTD
- Iqvia World Publications LTD.
- PHR Topco Limited
- Linguamatics Solutions Limited
- Iqvia Solutions UK Limited
- Q Squared Solutions Holdings Limited
- Prioritis Limited
- IMS Information Solutions Medical Research Limited
- Redsite Limited
- IMS Health Networks Limited
- Zebra Translations LTD
- Source Informatics Limited
- IMS Technology Solutions UK Limited
- Cambridge Pharma Consultancy Limited
- PHR Warehouse Limited
- Iqvia Finance LTD.
- Clinical LAB Minority Shareholder Limited
- Themis Limited
- Iqvia Investment Holdings Limited
- PHR Bidco Limited
- EPS Research Limited
- IMS Information Solutions UK Limited
- Albatross Financial Solutions LTD.
- Ardentia International Limited
- Iqvia Technology Services LTD.
- Linguamatics Limited
- Pharmaspectra Dollarco LTD
- Pharmadeals Limited
- Oxford Conversis Limited
- PHR Upper Midco Limited
- Q Squared Solutions China Limited
- Iqvia LTD.
- Apira Limited
- IMS (UK) Pension Plan Trustee Company Limited
- Infopharm Limited
- IMS Hospital Group Limited
- Infocus Health Limited
- CRO Solutions Limited
- Iqvia RDS Holdings
- Hospital Marketing Services Limited
- Iqvia Solutions Finance UK V LTD.
- PHR Lower Midco Limited
- Q Squared Solutions China (Quest) Limited
- Iqvia Laboratories LTD
- IMS Health Surveys Limited
- Pharmaspectra Midco 2 LTD
- Iqvia Biotech LTD.
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Financials
- Net assets
- £38,296,895
- Total assets
- £38,345,116
- Cash
- £33,216,149
- Employees
- 160
- Turnover
- £18,188,618
- Profit/loss
- £5,339,721
Figures from accounts filed at Companies House (iXBRL), period ending 2025-03-31. Where turnover is absent, small and micro-entity accounts are not required to report it, so it is not shown as zero.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
3 directors on the board
- Kevin John Turland Director · appointed 2025
- Andrea Morton-Morys Director · appointed 2025
- Kerry Louise Randall Director · appointed 2025
First-time vs portfolio directors
Portfolio (3)
- Kevin John Turland Director · appointed 2025
- Andrea Morton-Morys Director · appointed 2025
- Kerry Louise Randall Director · appointed 2025
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 03779957
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 30/09/2027
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data